• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kwality Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 68403.0
  • ISIN : INE552U01010
1,124.45 -20 (-1.79%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,119.25

  • Today’s High

    1,149.95

  • Open

    1,141.00

  • Perv Close

    1,144.90

  • 52W Low

    483.10

  • 52W High

    1,235.00

Key Indicators

  • P/E(TTM)

    29.25

  • Mar.Cap (₹Cr.)

    1,166.75

  • Div & Yield %

    0.00

  • Book Value(₹)

    255.44

  • Debt-Equity Ratio

    -1.79

  • AGM Date

    01-Aug-2025

  • EPS

    38.44

  • P/E Ratio

    29.25

Financials Ratios

  • Debt-Equity Ratio

    0.45

  • Mar.Cap (₹Cr.)

    1,166.75

  • RONW (%)

    13.66

  • ROCE (%)

    15.86

Score Board

  • Equity (₹ in Cr.)

    10.38

  • BV (₹)

    255.40

  • Sales( ₹ in Cr.)

    370.20

  • NP (in Cr.)

    39.89

  • NP Var(%)

    36.0

  • Div%

    0.0

  • CPS (₹)

    56.00

  • EPS (₹)

    38.40

  • Traded Value (₹ in Lakhs)

    1,166.75

  • 52 Week High

    1,235.00

  • 52 Week Low

    483.10

  • Price BSE

    1124.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    1,166.75

  • P/C Ratio

    20.10

  • P/E Ratio

    29.20

  • Price Vs.BV

    38.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 307.17 250.99 456.13 261.50 138.68 165.15
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 307.17 250.99 456.13 261.50 138.68 165.15
Other Income 1.83 2.94 3.51 1.59 3.92 0.93
Stock Adjustments 1.48 3.20 2.51 -0.09 5.52 -5.15
Total Income 310.48 257.13 462.15 263.00 148.12 160.93
EXPENDITURE :            
Raw Materials 154.66 113.27 203.11 165.50 92.59 114.19
Power and Fuel Cost 17.22 12.96 11.06 6.11 4.19 3.70
Employee Cost 30.43 28.10 18.74 14.48 10.68 7.61
Other Manufacturing Expenses 6.49 4.98 4.57 3.78 2.85 5.53
Selling and Administration Expenses 30.74 32.57 48.71 41.12 19.43 13.50
Miscellaneous Expenses 9.57 17.97 0.72 1.16 0.33 0.22
Employee Benefit Expenses 30.43 28.10 18.74 14.48 10.68 7.61
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 249.12 209.85 286.91 232.14 130.06 144.75
Operating Profit 61.37 47.29 175.24 30.86 18.05 16.17
Interest 10.39 6.61 2.92 2.62 2.52 2.22
Gross Profit 50.98 40.68 172.32 28.24 15.53 13.95
Depreciation 19.51 14.92 10.64 6.44 4.39 3.06
Profit Before Tax 31.47 25.76 161.68 21.80 11.14 10.89
Current Tax 7.92 6.16 41.35 6.22 3.03 3.44
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.44 0.14 0.27 0.16 -0.32 -0.09
Reported Net Profit 23.98 19.47 120.05 15.42 8.43 7.55
Extraordinary Items -5.31 -12.24 0.00 -0.01 0.08 0.00
Adjusted Net Profit 29.29 31.71 120.05 15.43 8.35 7.55
Adjustment below Net Profit -0.06 0.00 0.08 0.00 0.00 0.00
P & L Balance brought forward 182.38 162.91 42.78 27.37 18.94 11.39
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 206.30 182.38 162.91 42.78 27.37 18.94
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 23.11 18.76 115.69 14.86 8.13 7.27
Earnings Per Share(Adj)-Unit Curr 23.11 18.76 115.69 14.86 8.13 7.27
Book Value 216.98 193.93 175.17 59.47 44.62 36.49
Book Value(Adj)-Unit Curr 216.98 193.93 175.17 59.47 44.62 36.49

Shareholding Pattern

  • Promoter Group

    54.83%

  • Public Share Holding

    45.17%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 1,579,700 15.22 1,579,700 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,109,322 39.60 4,109,322 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,689,022 54.83 5,689,022 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 34,153 0.33 34,153 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 34,153 0.33 34,153 3
2] Non Institution
Bodies Corporate 198,792 1.92 198,792 61
Clearing Members 317 0.00 317 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 782,171 7.54 782,171 222
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 113,344 1.09 113,344 215
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,961,664 18.91 1,920,268 14
Individuals holding nominal share capital up to Rs. 1 lakh 1,496,195 14.42 1,496,195 9,590
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 100,540 0.97 100,540 1
Sub Total 4,653,023 44.84 4,611,627 10,105
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,376,198 100.00 10,334,802 10,115

Company Background

Kwality Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Kwality Pharmaceuticals Ltd
  • BSE Code : 68403.0
  • ISIN : INE552U01010

  • Incorporation Year

    1983

  • Registered Office

    Village Nagkalan
    Majitha Road, Amritsar,
    Punjab-143601

  • Telephone

    91-183-2774321-25

  • FAX

    91-183-2774477

  • Chairman

  • Managing Director

    Ramesh Arora

  • Company Secretary

    Gurpreet Kaur

  • Auditor

    Arora Aggarwal & Co/Vijay Mehra & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

Kwality Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kwality Pharma 1,124.45 309.00 307.17 29.25 15.90
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10